Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 3Plasma cell 2Other hematologic neoplasm 2Dermatologic 2Myeloid 1

Conditions

Leukemia, Myeloid, Acute 19Myelodysplastic Syndromes 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Myeloproliferative Disorders 14Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Mantle-Cell 11Leukemia, Myelomonocytic, Chronic 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Hodgkin Disease 11Lymphoma, Non-Hodgkin 10Multiple Myeloma 9Leukemia, Myeloid, Chronic-Phase 9Lymphoma, Large B-Cell, Diffuse 8Waldenstrom Macroglobulinemia 7Myelodysplastic-Myeloproliferative Diseases 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 7Primary Myelofibrosis 6Leukemia, Prolymphocytic 6Leukemia, Biphenotypic, Acute 6Lymphoma 5Leukemia 5Burkitt Lymphoma 5Blast Crisis 5Anemia, Refractory, with Excess of Blasts 5Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Graft vs Host Disease 4Congenital Abnormalities 4Pdgfra-Associated Chronic Eosinophilic Leukemia 3Lymphoma, Large-Cell, Immunoblastic 3

Interventions

fludarabine phosphate 21Peripheral Blood Stem Cell Transplantation 19Whole-Body Irradiation 15Mycophenolic Acid 13Cyclophosphamide 13Tacrolimus 11Cyclosporine 10Antilymphocyte Serum 10Melphalan 8Busulfan 8Methotrexate 7Therapeutics 4Sirolimus 4Etoposide 4Methylprednisolone 3Cord Blood Stem Cell Transplantation 3Carboplatin 3Alemtuzumab 3thymoglobulin 2sargramostim 2liposomal amphotericin B 2Thiotepa 2Rituximab 2Radiotherapy 2Psychiatric Rehabilitation 2Pentetic Acid 2Ondansetron 2Nivolumab 2Morphine 2Interferon-alpha 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Immunoblastic Lymphadenopathy × Cyclosporins × Myeloid × Clear all
NCT00513474 2017-05-25

Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant

Massachusetts General Hospital

Phase 1 Completed
46 enrolled 11 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Blast Crisis, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡